These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3359518)

  • 41. [On the demonstration of plasma cells in the cerebrospinal fluid in neurological diseases].
    Greger J; Wieczorek V
    Wien Z Nervenheilkd Grenzgeb; 1966; 23(4):366-74. PubMed ID: 4226908
    [No Abstract]   [Full Text] [Related]  

  • 42. [Significance of agar and immunoelectrophoresis studies of cerebrospinal fluid for neurological diagnostics].
    van Welsum RA
    Ned Tijdschr Geneeskd; 1970 Oct; 114(41):1718-20. PubMed ID: 5506427
    [No Abstract]   [Full Text] [Related]  

  • 43. Cerebrospinal fluid lactate dehydrogenase in neurological patients.
    Hardy JS; Holmes JE
    Bull Los Angeles Neurol Soc; 1967 Oct; 32(4):208-12. PubMed ID: 6056724
    [No Abstract]   [Full Text] [Related]  

  • 44. Assessment of the IgG index in dogs by indirect immunoenzimatic assays as diagnostic tool for inflammatory diseases of central nervous system.
    Mejías M; Molina MC; Ferreira A
    Res Vet Sci; 2008 Jun; 84(3):335-40. PubMed ID: 17716699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Lipids of the cerebrospinal fluid in some neurological disorders].
    Kovarík J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1974; 17(3):161-9. PubMed ID: 4534238
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon-inducible protein 10/CXCL10 is increased in the cerebrospinal fluid of patients with central nervous system lupus.
    Okamoto H; Katsumata Y; Nishimura K; Kamatani N
    Arthritis Rheum; 2004 Nov; 50(11):3731-2. PubMed ID: 15529358
    [No Abstract]   [Full Text] [Related]  

  • 47. [The C.S.F. protein formula in central nervous system diseases and especially in multiple sclerosis. Study of 218 examinations].
    Bizouard P; Guisard D; André JM; Arnould G
    Sem Hop; 1970 Jul; 46(31):2151-62. PubMed ID: 4195397
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cerebrospinal fluid protein].
    Igata A
    Naika; 1969 Jul; 24(1):105-9. PubMed ID: 5805506
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical cerebrospinal fluid diagnostics].
    Delank HW
    Nervenarzt; 1972 Feb; 43(2):57-68. PubMed ID: 4622639
    [No Abstract]   [Full Text] [Related]  

  • 50. [Lipids in the cerebrospinal fluid. Personal experience].
    Kovarík J; Votruba M; Krajícková D; Smelhausová E
    Cesk Neurol Neurochir; 1983 Mar; 46(2):77-82. PubMed ID: 6861235
    [No Abstract]   [Full Text] [Related]  

  • 51. The diagnostic significance of a protein binding nucleic acid in cerebrospinal fluid.
    Kubinski H; Javid M
    Surg Forum; 1971; 22():399-401. PubMed ID: 5121419
    [No Abstract]   [Full Text] [Related]  

  • 52. Central nervous system involvement as a presenting feature of acute monocytic leukemia: preceding leukemia by 12 months.
    Hamous JE; Ansbacher LE; Armitage JO; Dick FR
    Am J Clin Pathol; 1983 Aug; 80(2):242-5. PubMed ID: 6576628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoglobulins in cerebrospinal fluid in central nervous system disorders.
    Varavi SF; Kamat JR; Joshi MK; Kandoth PW
    Indian J Pediatr; 1982; 49(400):665-9. PubMed ID: 7188189
    [No Abstract]   [Full Text] [Related]  

  • 54. [New aspects in cerebrospinal toxoplasmosis (author's transl)].
    Stöckli HR; Kaeser HE; Kocher R; Dietrich R; Rieder HP
    Fortschr Neurol Psychiatr Grenzgeb; 1980 Jun; 48(6):303-13. PubMed ID: 6997156
    [No Abstract]   [Full Text] [Related]  

  • 55. Monoclonal and polyclonal antibodies against neural antigens: diagnostic applications for studies of central and peripheral nervous system tumors.
    Trojanowski JQ; Lee VM
    Hum Pathol; 1983 Apr; 14(4):281-5. PubMed ID: 6299924
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunohistochemistry of tumors of the nervous system].
    Poirier J; Gray F; Gherardi R
    Arch Anat Cytol Pathol; 1987; 35(2):116-27. PubMed ID: 3307647
    [No Abstract]   [Full Text] [Related]  

  • 57. Cerebrospinal fluid interleukin-6 levels: a possible marker of disease activity.
    Jellinger KA; Rösler N; Wichart I
    Ann Neurol; 2001 Dec; 50(6):828. PubMed ID: 11761489
    [No Abstract]   [Full Text] [Related]  

  • 58. Anti-neurofilament monoclonal antibodies: reagents for the evaluation of human neoplasms.
    Trojanowski JQ; Lee VM
    Acta Neuropathol; 1983; 59(2):155-8. PubMed ID: 6682279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunopathology of the nervous system. II. Antigens of the nervous system (second of five parts).
    Morrell RM
    Allergol Immunopathol (Madr); 1977; 5(2):151-4. PubMed ID: 878972
    [No Abstract]   [Full Text] [Related]  

  • 60. [Monoclonal antibodies. Acquisition and use in medicine].
    Gargouri J; Ayadi H; Souissi T; Ayed K
    Tunis Med; 1988 Jan; 66(1):5-12. PubMed ID: 3059626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.